Siponimod (multiple sclerosis) - Addendum to Commission A20-10

Report documents

1. Addendum

   Siponimod (multiple sclerosis) - Addendum to Commission A20-10

   published on

   20.08.2020

   Document type

   PDF document, 214 kB, EN, not accessible

   Download file : Addendum (PDF document, 214 kB, EN, not accessible)

Additional information

Project details

Project no.

A20-51

Commission

Commission awarded on 23.06.2020 by the Federal Joint Committee (GBA).

Report type

Addendum

Status

Commission completed

Department/Division

Drug Assessment

Topic

Head and nerves

Note

If the need for additional work on a project commissioned by the GBA arises during consultations, IQWiG submits an addendum. The subsequent decides on the extent of the added benefit concludes the early benefit assessment.

Connected Projects

1. Dossier assessment

   Siponimod (multiple sclerosis) - Benefit assessment according to §35a Social Code Book V

   Project no.

   A20-10

   Last updated

   20.08.2020

   Status: Commission completed